Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Interest & Investment Income (2020 - 2025)

Pulse Biosciences has reported Interest & Investment Income over the past 6 years, most recently at $1.0 million for Q3 2025.

  • Quarterly results put Interest & Investment Income at $1.0 million for Q3 2025, up 2.56% from a year ago — trailing twelve months through Sep 2025 was $4.2 million (up 76.26% YoY), and the annual figure for FY2024 was $2.7 million, up 95.89%.
  • Interest & Investment Income for Q3 2025 was $1.0 million at Pulse Biosciences, down from $1.1 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for PLSE hit a ceiling of $1.2 million in Q1 2025 and a floor of -$517000.0 in Q2 2021.
  • Median Interest & Investment Income over the past 5 years was $330000.0 (2023), compared with a mean of $349555.6.
  • Biggest five-year swings in Interest & Investment Income: tumbled 7433.33% in 2022 and later surged 5000.0% in 2023.
  • Pulse Biosciences' Interest & Investment Income stood at -$6000.0 in 2021, then tumbled by 7433.33% to -$452000.0 in 2022, then soared by 232.74% to $600000.0 in 2023, then soared by 44.67% to $868000.0 in 2024, then increased by 15.32% to $1.0 million in 2025.
  • The last three reported values for Interest & Investment Income were $1.0 million (Q3 2025), $1.1 million (Q2 2025), and $1.2 million (Q1 2025) per Business Quant data.